Not provided
Not provided
Not provided
Not provided
Not provided
Principal Investigator left Duke University
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this single institution pilot study is to determine the feasibility of implementing an eHealth prostate cancer surveillance program through the eVisit electronic medical record patient portal. The investigators will assess patient compliance and satisfaction with eVisit follow up care in lieu of in person clinic visits.
Telehealth offers the opportunity to transform cancer surveillance into a patient-centered effort with shared leadership between patient and oncologist. Peer-to-peer electronic communications can improve the collaboration between oncologist and primary care provider (PCP) as patients transition back to primary care as their primary health provider. The investigators propose to test a patient-centered eHealth surveillance program utilizing novel asynchronous telehealth tools to provide patient-reported outcome symptom monitoring using the electronic medical record's patient portal (eVisit).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| eVisit | Experimental | The study intervention will be an electronically performed surveillance program replacing face-to-face clinic follow-up visits. At 3 month intervals for 1 year, the patient will receive an email reminder generated by the patient portal to complete lab testing and eVisit questionnaire. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| eVisit | Other | electronic surveillance program in lieu of in-person clinic visit |
|
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of patients who complete all scheduled eVisits at the end of follow-up | Defined as completion of labwork and at least 80% of the questions asked at each eVisit | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility of enrollment to the eVisit program | Defined as the percentage of patients who are approached for eVisit and ultimately enroll | 12 months |
| eVisit participant reported satisfaction | Reported as the summary score from validated Brief Patient Satisfaction 10-item scale instrument assessed from "1/strongly agree" through "5/strongly disagree" |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bridget Koontz, MD | Duke Health | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Duke Cancer Institute Cary | Cary | North Carolina | 27518 | United States | ||
| Durham Regional Hospital |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011471 | Prostatic Neoplasms |
| ID | Term |
|---|---|
| D005834 | Genital Neoplasms, Male |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 12 months |
| Number of participants with cancer treatment related toxicities | Defined specifically as CTCAE Grade 2 or higher GI, GU, hormonal, and sexual toxicities | 12 months |
| Number of eVisit participants with cancer recurrence | Defined as biochemical progression (PSA >0.2 ng/ml for prostatectomy patients or nadir + 2 ng/ml for radiation patients) or metastasis (by imaging) | 12 months |
| Financial impact of the eVisit program on participants compared to in person follow up clinic visits | Defined by the financial burden assessment completed by participants, scored from "0/not at all" through "4/very much" | 12 months |
| Financial impact of the eVisit program on Duke University Hospital (institution) compared to in person follow up | Defined by percentage of participants/eVisits covered by insurance | 12 months |
| Financial impact of the eVisit program on Duke University Hospital (institution) compared to in person follow up | Defined by qualitative analysis of time commitment for providers | 12 months |
| Financial impact of the eVisit program on Duke University Hospital (institution) compared to in person follow up | Defined by qualitative analysis of reimbursement process | 12 months |
| Durham |
| North Carolina |
| 27704 |
| United States |
| Duke University Medical Center | Durham | North Carolina | 27710 | United States |
| Duke Raleigh Hospital | Raleigh | North Carolina | 27609 | United States |
| D005832 |
| Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D011469 | Prostatic Diseases |
| D052801 | Male Urogenital Diseases |